Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2013

Cambon Karine, Déglon Nicole

Abstract excerpt

This chapter describes the potential use of viral-mediated gene transfer in the central nervous system for the silencing of gene expression using RNA interference in the context of Huntington's disease (HD). Protocols provided here describe the design of small interfering RNAs, their encoding in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Transfer Techniques
Share to Genetic Therapy
Share to Genetic Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Huntingtin Protein

Share to Huntington Disease

Share to Lentivirus

Share to Nerve Tissue Proteins

Share to RNA, Small Interfering

Source

Identifiers

PMID: 23754221
DOI: 10.1007/978-1-62703-411-1_7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23754221-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.PMID 23754221Read ↗

Using non-coding small RNAs to develop therapies for Huntington's disease.Semantic proximity Read ↗

Delivering a disease-modifying treatment for Huntington's disease.Semantic proximity Read ↗

CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.Semantic proximity Read ↗

AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.Semantic proximity Read ↗

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection.Semantic proximity Read ↗

The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders.Semantic proximity Read ↗

Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.Semantic proximity Read ↗

Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease models.Semantic proximity Read ↗

Mouse Models of Huntington's Disease.Semantic proximity Read ↗

Sustained effects of nonallele-specific Huntingtin silencing.Semantic proximity Read ↗

The potential of gene editing for Huntington's disease.Semantic proximity Read ↗

[Gene silencing approaches for the treatment of Huntington's disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.